GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Guangxi LiuYao Group Co Ltd (SHSE:603368) » Definitions » Capex-to-Revenue

Guangxi LiuYao Group Co (SHSE:603368) Capex-to-Revenue : 0.01 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Guangxi LiuYao Group Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Guangxi LiuYao Group Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-32.80 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥5,774.67 Mil.

Hence, Guangxi LiuYao Group Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.01.


Guangxi LiuYao Group Co Capex-to-Revenue Historical Data

The historical data trend for Guangxi LiuYao Group Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangxi LiuYao Group Co Capex-to-Revenue Chart

Guangxi LiuYao Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.02 0.01 0.01

Guangxi LiuYao Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - 0.01 0.01 0.01

Competitive Comparison of Guangxi LiuYao Group Co's Capex-to-Revenue

For the Medical Distribution subindustry, Guangxi LiuYao Group Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangxi LiuYao Group Co's Capex-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangxi LiuYao Group Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Guangxi LiuYao Group Co's Capex-to-Revenue falls into.



Guangxi LiuYao Group Co Capex-to-Revenue Calculation

Guangxi LiuYao Group Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-172.944) / 20811.903
=0.01

Guangxi LiuYao Group Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-32.802) / 5774.668
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangxi LiuYao Group Co  (SHSE:603368) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Guangxi LiuYao Group Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Guangxi LiuYao Group Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangxi LiuYao Group Co (SHSE:603368) Business Description

Traded in Other Exchanges
N/A
Address
No. 68 Guantang Avenue, Guangxi Zhuang Autonomous Region, Liuzhou, CHN, 545000
Guangxi LiuYao Group Co Ltd is a regional pharmaceutical distribution enterprise focusing on hospital sales and developing both retail pharmacies and third terminals.
Executives
Tang Xian Rong Director
Chen Hong Directors, senior managers
Tang Chun Xue Directors, senior managers
Zhang Hua Director
Ceng Xiang Xing senior management
Zhu Xian Hua senior management
Su Chun Yan senior management
Chen Xiao Yuan Supervisors
Zhu Chao Yang Directors, senior managers
Tang Jie Yu senior management
Qiu Zhi Meng senior management
Shen Wen Jie senior management
Xiao Jun Xiong Director
Ceng Song Lin Director

Guangxi LiuYao Group Co (SHSE:603368) Headlines

No Headlines